Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4939-2074-7_21PMID 26272151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics.

  2014cited by this paper
• In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development

  2013cited by this paper
• Transporters in Drug Development and Clinical Pharmacology

  2013cited by this paper
• Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

  2013cited by this paper
• Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective

  2013cited by this paper
• Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.

  2013cited by this paper
• The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance

  2012cited by this paper
• Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

  2012cited by this paper
• Absolute Quantification and Differential Expression of Drug Transporters, Cytochrome P450 Enzymes, and UDP-Glucuronosyltransferases in Cultured Primary Human Hepatocytes

  2012cited by this paper
• Drug transport by Organic Anion Transporters (OATs).

  2012cited by this paper
• In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation

  2012cited by this paper
• In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.

  2011cited by this paper
• Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms.

  2011cited by this paper
• Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

  2011cited by this paper
• Transporter-mediated drug-drug interactions.

  2011cited by this paper
• Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.

  2011cited by this paper
• Coexistence of passive and carrier-mediated processes in drug transport

  2010cited by this paper
• Isolation and culture of primary hepatocytes from resected human liver tissue.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cited by this paper
• In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.

  2009cited by this paper
• Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

  2008cited by this paper
• Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures.

  2008cited by this paper
• The role of hepatic transporters in drug elimination

  2008cited by this paper
• Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

  2007cited by this paper
• Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs

  2006cited by this paper
• Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance

  2006cited by this paper
• Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

  2006cited by this paper
• INHIBITION OF OAT3-MEDIATED RENAL UPTAKE AS A MECHANISM FOR DRUG-DRUG INTERACTION BETWEEN FEXOFENADINE AND PROBENECID

  2006cited by this paper
• FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES

  2005cited by this paper
• Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

  2004cited by this paper
• Enterohepatic bile salt transporters in normal physiology and liver disease.

  2004cited by this paper
• Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.

  2002cited by this paper
• Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

  2002cited by this paper
• Substrate specificity of the rat liver Na+-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.

  1998cited by this paper
• Metabolic capacities in cultured human hepatocytes obtained by a new isolating procedure from non-wedge small liver biopsies

  1998cited by this paper
• Functional human hepatocytes: isolation from small liver biopsy samples and primary cultivation with liver-specific functions.

  1995cited by this paper
• Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.

  1994cited by this paper
• High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver.

  1982cited by this paper
• Isolation, culture, and transplantation of human hepatocytes.

  1982cited by this paper
• Interaction of Human Organic Anion Transporters 2 and 4 with Organic Anion Transport Inhibitors Experimental Procedures

  year unknowncited by this paper

• Qiwei Jinggan Ling regulates oxidative stress and lipid metabolism in alcoholic liver disease by activating AMPK.

  2024cites this paper
• Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters

  2021cites this paper
• In vitro studies with two human organic anion transporters: OAT2 and OAT7

  2018influential citation
• Simvastatin down-regulates differential genetic profiles produced by organochlorine mixtures in primary breast cell (HMEC).

  2017cites this paper
• Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes

  2017cites this paper
• Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.

  2016cites this paper
• Development of genotyping systems for pharmacogenomics profiling

  2016cites this paper
• Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells

  2016cites this paper
• Régulation de l'expression fonctionnelle de transporteurs membranaires dans des cellules hépatocytaires et pulmonaires exposées aux extraits de particules diesel

  2015cites this paper
• TXEN-2017-0256 Revised In Vitro Studies with Two Human Organic Anion Transporters : OAT 2 and OAT 7

  year unknowninfluential citation